Polsinelli

The USPTO announced a set of finalized fee increases and new fees to take effect on January 19, 2025. Jacek Wnuk reviews some of the new fees in the latest update: https://lnkd.in/gK3Gvwcd.   #uspto #patentfilings #intellectualproperty

We are excited to share that Jim DelBello has been appointed Vice Chair of our Commercial Litigation Practice. #whatalawfirmshouldbe #commerciallitigation #litigationlaw

The Office of Federal Contractor Compliance Programs recently published its Corporate Scheduling Announcement List online, identifying contractors receiving an audit scheduling letter in the coming year. Read the latest Polsinelli at Work blog from Erin Schilling and Shivani Patel Bailey to get more details on the list and how to take advantage of this valuable preparation time: https://lnkd.in/g4UsCgds. #ofccp #CSAL #governmentcontracts #polsinelliatwork

Grateful to once again celebrate another year with clients at our New York office's annual Client Appreciation Event. It is always an incredible time when we get a chance to connect outside of work to reflect on our journey together. Here's to many more impactful collaborations ahead! #whatalawfirmshouldbe #clientappreciation #polsinellinewyork

Explore the key components of Cybersecurity Maturity Model Certification and discuss how to leverage the CMMC framework to achieve more than just compliance for your business with us and CohnReznick LLP on Tuesday, December 10th. Polsinelli Shareholders Erin Felix, Sarah Glover and James Kim, JD/MPH, along with CohnReznick's Directors, Cybersecurity, Technology Risk and Privacy Daryouche Behboudi and Stephen Gilmer, CCISO, will give you the practical tips and strategies to gain the CMMC advantage and elevate your cyber program: https://lnkd.in/g6y7PAkC.   #cybersecurity #cmmc #cmmccompliance

Our team of FDA and Medicare regulatory attorneys and public policy advisors recently counseled Avanos Medical, a medical technology company focused on delivering clinically superior medical device solutions, in meeting qualifying requirements for separate payment for two of its devices under the NOPAIN Act. Vice Chair Michael Gaba led the team advising and advocating for Avanos over the past several years, that included Shareholder Steven Stranne MD and Senior Policy Advisors Shelagh Foster and Tim Perrin: https://lnkd.in/gXBeRPB6. #whatalawfirmshouldbe #fda #medicaldevices #nopainact

The Houston office enjoyed hosting clients and colleagues for a unique social darts experience at Flight Club. Thank you to all who attended, and we look forward to seeing you at future events! #polsinellihouston #clientevent #whatalawfirmshouldbe

We recently advised Astrana Health in entering into a definitive agreement to acquire a portion of the business and assets of Prospect Health. Astrana Health is a provider-centric, technology powered leading health care company that enables providers to deliver accessible, high quality and high value care in the communities they serve. This transaction will create a more coordinated care delivery network by increasing access, quality, value and efficiency: https://lnkd.in/gC29StcM. #whatalawfirmshouldbe #healthcare #acquisitions

We are pleased to welcome Rachel Adams to our nationwide Health Care Practice as a shareholder in the Chicago office from an Am Law 100 firm. Rachel has more than a decade of experience and focuses her practice on advising health care clients in general corporate matters and complex transactions ranging from affiliations to acquisitions while ensuring compliance with regulatory requirements: https://lnkd.in/gUmJbPKu.   #whatalawfirmshouldbe #polsinellichicago #healthcare

We are excited to have Amy McVeigh co-lead an interactive working group at the American Conference Institute’s 29th Annual Conference on Drug & Medical Device Litigation. Workshop leaders will guide you through key components as you tackle the unique challenges of mass-tort MDLs, providing a robust foundation for broader conference discussions: https://lnkd.in/gpkr_Z_p.   #mdldefense #drugandmed2024 #aciconferences